Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

NCT02547818 is registered in ClinicalTrials.gov with AZTherapies, Inc. as lead sponsor.

NCT NCT02547818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02547818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Lead sponsor
AZTherapies, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2015
Completion date
November 18, 2020
Enrollment
620 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease